Levipil
Brand Name: Levipil
Generic Name: Levetiracetam
Active
Registration Number
DRP-11418
Dosage Form
Concentrate Solution for IV Infusion
Issuance Date
June 4, 2024
Expiry Date
May 9, 2028
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength100 mg/mL
Packaging5 mL (Net Content) Type I clear and colorless glass vial with 20 mm gray bromobutyl rubber stopper and 20 mm aluminum seal with green plastic flip-off cap (Box of 1's)
Classification
C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Antiepileptic
A
Application
Initial (Variation) (Correction)
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
LevetiracetamActive
Monograph: Levetiracetam